CNS Flashcards
(85 cards)
Which of the following agents has a pure beta agonist effect in the circulation?
A Adrenaline
B Dopamine
C Noradrenaline
D Isoprenaline
D
Explanation
Adrenaline is a very potent vascular bed vasoconstrictor (alpha R) and a cardiac stimulant (B R).
NA is a very potent vascular bed vasoconstrictor (Alpha R) and has B1 effects on the heart.
Isoprenaline activates B receptors almost exclusively and is a potent vasidilator.
Dopamine effects several D1 R vascular bed (Vasodilatation) and at a higher doses B and A receptors
Extra: Agonists
Phenylephrine a1>a2»»b
Clonidine a2>a1»»b
Dobutamine b1>b2»»a Isoproterenol (Isoprenaline) b1=b2»»a
Terbutaline, Albuterol, Metaproterenol b2»b1»»a1
Dopamine D1=D2»b»a Fenoldopam D1»D2
Noradrenaline: b1»b2, a1=a2
Adrenalne: b1=b2, a1=a2
Which of the following statements regarding carbamazepine is correct?
A Sodium valproate increases carbamazepine clearance
B Overdose causes seizures
C It metabolises to non-active metabolites.
D It is an enzyme inhibitor
B
Explanation
Overdose can cause seizures but the most common side effects are diplopia and ataxia. Foetal aplastic anaemia and agranulocytosis can also occur. Carbamazepine in an enzyme inducer and has active metabolites. Sodium valporate inhibits carbamazapine clearance whereas phenytoin and phenobarbitone increase clearance
Regarding L-dopa, which of the following statements is correct?
A It causes a negative Coombs test.
B It has a half life of 5 hours
C 25% of the oral dose reaches the brain
D It is a precursor to dopamine
D
Explanation
L-dpoa is an immediate precursor of dopamine. 1-3% enters the brain unaltered, but this number will be higher if given with dopa decarboxylase inhibitor. Concomitant administration of a peripheral dopa decarboxylase inhibitor (carbidopa) may reduce the daily requirement of levodopa by approximately 75%. L-dopa causes a positive Coombs test. L-dopa has a half life of between 1-3 hours.
Regarding ergotamine, which of the following statements is incorrect?
A It works well in the early treatment of acute migraine
B It can be given parenterally
C It causes GI haemmorhage
D It causes vasoconstriction
C
Explanation
Ergotamine can be administered orally, via rectum, via aerosol inhaler and intramuscular injection. Ergot derivatives are highly specific for migraine pain. They are not analgesic for any other condition. The vasoconstriction (partial agonist effects at alpha adrenoreceptors and some as a result of effects at 5-HT receptors) produced by ergotamine is long lasting and cumulative. The direct receptor stimulation thus prevents vasodilatation and stretching of the pain endings. The most toxic effects of the ergot derivatives are GIT disturbances, including diarrhoea, nausea and vomiting. GIT haemorrhage does not occur. There have been reports of bowel infarction/ischaemia due to blood vessel vasoconstriction
–ChatGPT–
Ergotamine is an ergot alkaloid derived from the fungus Claviceps purpurea. It primarily acts as a vasoconstrictor and is used in the treatment of certain types of headaches, such as migraine and cluster headaches.
Mechanism of Action:
1. Partial Agonist/Antagonist at Serotonin Receptors:
- Acts on 5-HT1 and 5-HT2 receptors in cranial blood vessels, causing vasoconstriction. This reduces the vasodilation thought to contribute to migraines.
2. Agonist/Antagonist at Dopaminergic Receptors:
- Can affect dopaminergic pathways, contributing to its diverse effects.
3. Alpha-Adrenergic Effects:
- Acts as a partial agonist on α-adrenergic receptors, enhancing vasoconstriction.
Inhibition of Neurogenic Inflammation:
Reduces the release of inflammatory neuropeptides involved in migraine pathophysiology.
Uses:
- Migraine Treatment: Particularly effective in stopping migraines during the prodrome or early stages.
- Cluster Headaches: Sometimes used for acute attacks.
Side Effects:
1. Vasoconstrictive Effects:
- Can cause peripheral ischemia (e.g., cold, pale extremities, cyanosis).
- Severe vasospasm may lead to gangrene in rare cases.
- Gastrointestinal Symptoms:
- Nausea, vomiting, and abdominal pain are common due to stimulation of the chemoreceptor trigger zone. - Central Nervous System Effects:
Dizziness, confusion, or drowsiness.
Ergotism (Toxicity):
Symptoms include intense vasoconstriction, ischemia, muscle pain, and, in severe cases, hallucinations or seizures.
Dependency:
Chronic use may lead to rebound headaches or medication-overuse headaches.
Contraindications:
1. Cardiovascular Disease:
Avoid in patients with coronary artery disease, peripheral vascular disease, or hypertension due to the risk of severe vasoconstriction.
- Pregnancy:
Category X: Can cause uterine contractions and miscarriage. - Liver or Kidney Impairment:
Metabolized by the liver and excreted by the kidneys, requiring caution in dysfunction.
Concurrent Use with CYP3A4 Inhibitors:
Co-administration (e.g., with certain antifungals or macrolides) increases the risk of ergot toxicity.
Important Notes:
Ergotamine is often combined with caffeine (e.g., in formulations like Cafergot) to enhance its absorption and effectiveness.
Modern migraine treatments (e.g., triptans and CGRP inhibitors) have largely replaced ergotamine due to its side-effect profile.
Summary:
Ergotamine is a potent vasoconstrictor used for migraine and cluster headache treatment but carries significant risks, including vasospasm and ergotism. It requires careful monitoring and is typically reserved for cases where other treatments are ineffective.
Regarding drugs that are used to treat glaucoma, which is the correct pairing of drug-mechanism of action?
A Latanoprost - increased aqueous production.
B Pilocarpine - ciliary muscle contraction
C Acetazolamide - increased aqueous production
D Timolol - ciliary muscle contraction
B
Explanation
Pilocarpine: acts on a subtype of muscarinic receptor (M3) found on the iris sphincter muscle, causing the muscle to contract -resulting in pupil constriction (miosis). Pilocarpine also acts on the ciliary muscle and causes it to contract. When the ciliary muscle contracts, it opens the trabecular meshwork through increased tension on the scleral spur. This action facilitates the rate that aqueous humor leaves the eye to decrease intraocular pressure.
Timolol - decreases aqueous secretion.
Acetazolamide - decreases aqueous secretion due to a lack of HCO3.
Latanoprost - increased outflow of aqueous.
PG - increased outflow.
Beta blockers - decreased aqueous secretion
Which of the following statements regarding neuromuscular junction blockers is incorrect?
A Pancuronium and vecuronium are both steroid neuromuscular blocking drugs
B Vecuronium is predominantly renally excreted
C Pancuronium has a longer duration of action than vecuronium
D Atracurium is inactivated by Hofmann elimination
B
Explanation
Vecuronium is excreted by the liver- 85% and renal- 15%.
Pancuromium’s duration of action is >35m and vecuronium’s 20-35min.
Vecuronium, pancuronium, pipecuronium and rocuronium are steroidal neuromuscular blocking drugs.
Tubocurarine, atracurium and doxacurium are isoquinoline neuromuscular blocking drugs.
Atracurium is inactivated by Hofmann elimination
Note: Atracurium is so extensively metabolised that its pharmacokinetics are independent of renal and hepatic function, and less than 10% is excreted unchanged by renal and biliary routes. Two separate processes are responsible for metabolism:
Ester hydrolysis- this action is catalysed by non-specific esterases, not by acetylcholinesterase or pseudocholinesterase.
Hofmann elimination- a spontaneous non-enzymatic chemical breakdown occurs at physiologic pH and temperature
A young male presents with a high blood pressure, mydriasis and a high temperature. Which drug has he most likely taken?
A Cocaine
B Atropine
C Naloxone
D Adrenaline
A
Explanation
Cocaine is a sympathomimetic stimulant which cause cardiovascular, CNS and peripheral sympathetic stimulation
Atropine: the net cardiovascular effects of atropine in patients with normal haemodynamics are not dramatic: tachycardia may occur, but there is little effect on blood pressure.
Anticholinegic syndrome: includes central and peripheral effects e.g. tachycardia, CNS effects and hyperthermia. It does not include hypertension however.
Not a great question
In reality, all these drugs can cause the above symptoms. However, atropine and adrenaline are not frequently ingested, nor abused. Naloxone won’t cause the symptom profile unless it put the patient into opioid withdrawal. In other words the most likely drug taken is cocaine-it is easily ingested and the most abused and causes these symptoms
Regarding sodium valproate, which of the following statements is correct?
A It is highly protein bound
B It’s VD is 0.6L/kg
C T1/2 is 40 hrs
D It has a high first pass metabolism
A
Explanation
Sodium valproate (SV) is readily absorbed form the GIT. Its bioavailability is greater than 80% so it has a low first pass metabolism rate. Half-life varies from 9-18hrs. Peak blood levels are observed within 2 hrs. pKa of 4.7. 90% bound to plasma proteins. SV has a VD of 0.15L/kg (it is essentially confined to extracellular water). It is fully ionized at a normal body pH. Clearance of SV is low and dose dependent. Approximately 20% of the drug is excreted as a direct conjugate of valproate
Which of the following statements regarding L-Dopa is correct?
A Ingesting L-dopa with food does not delay its absorption
B L-dopa’s half life is unaffected when given with carbidopa
C Drug holidays are recommended to improve the the responsiveness to levodopa
D Suddenly stopping it will cause tremor
D
Explanation
L-dopa is an immediate precursor of dopamine. L-dopa is rapidly absorbed from the small intestine, but its absorption depends on the rate of gastric emptying and the pH of the gastric contents. Food will delay the appearance of L-dopa in the plasma. Ingested food can compete with the drug for absorption from the gut and for transport from the blood to the brain.
Note: When levodopa is given without a peripheral decarboxylase inhibitor, anorexia, nausea & vomiting occur in about 80% of patients. These adverse effects can be minimised by taking the drug in divided doses, with or immediately after meals or by increasing the total daily dose slowly. It is better to add carbidopa, as the prevalence of adverse effect occur in less than 20% of patients.
1-3% enters the brain unaltered, but this number will be higher if given with dopa decarboxylase inhibitor. Concomitant administration of a peripheral dopa decarboxylase inhibitor (carbidopa) may reduce the daily requirement of levodopa by approximately 75%. L-dopa causes a positive Coombs test. L-dopa has a half-life of between 1-3 hours but when administered with carbidopa, the plasma half-life is longer. Suddenly stopping L-dopa will cause tremor. This side effect part of the neuroleptic malignant syndrome that may occur on abrupt stopping of the drug. Because a drug holiday may only temporarily improve responsiveness to levodopa (but is of little benefit in preventing the on off phenomenon) and due to the risks of aspiration, PE, venous thromboembolism and depression (from the increasing immobility) during a drug holiday, they are not recommended.
What is the most common adverse effect of procainamide?
A Anaphylaxis
B Bradycardia
C Hypotension
D Fever
C
Explanation
Hypotension especially when administered IVI as it has ganglion-blocking properties
Procainamide is a Class Ia antiarrhythmic drug used to treat various cardiac arrhythmias. It works by altering the electrical activity of the heart to restore and maintain normal heart rhythm.
Mechanism of Action:
1. Sodium Channel Blockade:
Blocks fast sodium channels in the cardiac cells, reducing the rate of depolarization during Phase 0 of the action potential.
Slows conduction velocity, particularly in the atria, ventricles, and His-Purkinje system.
- Potassium Channel Effects:
Prolongs repolarization by inhibiting outward potassium currents, thereby increasing the action potential duration (APD) and effective refractory period (ERP).
- Overall Effects:
Slows conduction.
Prolongs the QRS complex and QT interval on an ECG.
Clinical Uses:
1. Atrial and Ventricular Arrhythmias:
- Treats supraventricular tachycardia (SVT) and atrial fibrillation (AF) associated with pre-excitation syndromes (e.g., Wolff-Parkinson-White syndrome).
2. Ventricular Tachycardia:
Used for hemodynamically stable monomorphic ventricular tachycardia (VT).
3. Conversion of Arrhythmias:
Effective for converting certain arrhythmias to sinus rhythm.
Pharmacokinetics:
- Administration: Can be given orally, intravenously, or intramuscularly.
- Metabolism: Metabolized in the liver to N-acetylprocainamide (NAPA), which has Class III antiarrhythmic properties (prolongs repolarization).
- Excretion: Renally excreted; dose adjustment is required in renal impairment.
Side Effects:
1. Cardiovascular:
- Hypotension (common with IV administration).
- Prolongation of QT interval, increasing the risk of torsades de pointes.
- Worsening of arrhythmias (proarrhythmic effects).
- Hematological:
- Agranulocytosis: A rare but severe side effect requiring regular monitoring of blood counts. - Systemic Lupus Erythematosus (SLE)-Like Syndrome:
- Long-term use may cause a reversible lupus-like syndrome (fever, arthralgia, rash, and positive antinuclear antibodies). - Gastrointestinal:
Nausea, vomiting, and diarrhea. - Others:
Fatigue, dizziness, and rash.
Contraindications:
1. Heart Block:
Avoid in patients with second- or third-degree heart block without a pacemaker.
- Torsades de Pointes:
Contraindicated in patients with a history of this arrhythmia or congenital long QT syndrome. - Severe Heart Failure:
Negative inotropic effects can worsen cardiac output.
Key Monitoring Parameters:
1. ECG Monitoring:
Watch for QRS widening and QT prolongation.
2. Blood Pressure:
Monitor for hypotension during IV administration.
3. Complete Blood Count (CBC):
Regular monitoring for agranulocytosis.
4. Renal Function:
Adjust dose in renal impairment.
Summary:
Procainamide is a versatile antiarrhythmic drug effective for treating a range of arrhythmias, particularly in acute settings. However, its use is limited by potential side effects such as lupus-like syndrome, QT prolongation, and proarrhythmia. Careful monitoring is essential to ensure safe and effective treatment.
A patient complains of muscle pain post-operatively. Which of the following drugs is most likely to cause this?
A Ketamine
B Propofol
C Atracurium
D Suxamethonium
D
Explanation
Muscle pain due to the depolarizing action of suxamethonium.
Which of the following muscle relaxants has the longest duration of action?
A Rocuronium
B Atracurium
C Vecuronium
D Pancuronium
D
Explanation
Mivacurium - 10-20m
Atracurium - 20-35m
Vecuronium - 20-35m
Rocuronium - 20-35m
Pancuronium - 35-45 min
Which of the following drugs has the greatest MAC?
A Methoxyflurane
B Nitrous oxide
C Isoflurane
D Halothane
B
Explanation
NO - 100%
Halothane - 0.75%
isoflurane - 1.4%
methoxyflurane - 0.16%
All the following drugs are anaesthetic agents except?
A Etomidate
B Midazolam
C Propofol
D Glycopyrolate
D
Explanation
Propofol is a hypnotic/amnesic used for induction and maintenance of general anaesthetic.
Midazolam is a benzodiazepine amnesiac used for sedation during GA.
Etomidate (GABA receptors) is used in ED for conscious sedation and RSI.
Glycopyrolate is a muscarinic antagonist that is used during sedation to dry up oral secretions.
At low dose, which of the following muscle relaxants is most commonly associated with tachycardia?
A Gallamine
B Suxamethonium
C Vecuronium
D Atracurium
A
Explanation
Vecuronium, pipecuronium, rocuronium have little or no CVS effects. Pancuronium causes a modest increase in HR (vagolytic or by blockade of norepinephrine from adrenergic ending)and a smaller increase in cardiac output, with little or no change in systemic vascular resistance. Atracurium has no effects on autonomic ganglia or on cardiac muscarinic receptors but may cause cardiovascular effects that are mediated by autonomic or histamine receptors.
Gallamine increases heart rate by both vagolytic action and sympathetic stimulation.
Succinylcholine causes various cardiac arrhythmias. The drug stimulates all autonomic cholinoreceptors. In low doses, negative inotrope and chronotrope occur, in higher doses positive inotropic and chronotropic effects may occur. Bradycardia is often observed when a second dose of the drug is given within 5minutes.
Extra:
An old question. Gallamine is not used in clinical practice. All questions are left in the bank as tools for learning.
Which of the following drugs is not an amide local anaesthetics?
A Prilocaine
B Lignocaine
C Benzocaine
D Bupivicaine
C
Explanation
Other amide local anaesthetics include mepivacaine, etidocaine and ropivocaine.
Extra:
Amide local anaesthetics have two “i”s in their names i.e lignocaine, prilocaine, bupivicaine.
Esters only have one “i” in their names i.e. Procaine, benzocaine
Which of the following is an ester local anaesthetic?
A Prilocaine
B Tetracaine
C Bupivicaine
D Lignocaine
B
Explanation
Ester local anaethetics: cocaine, procaine, tetracaine, benzocaine.
Note: A memory aid to memorize, which LA is an ester and which is amide. Amides have two “i’s” in the name (e.g. Lignocaine) Esters have only one “i” in the name (e.g. Benzocaine)
Regarding neuromuscular junction blockers, which of the following statements is correct?
A Gentamicin increases their efficacy
B Pancuronium causes histamine release
C Gallamine is eliminated by the liver
D Vecuronium is an isoquinolone derivative
D
Explanation
Pancuronium does not cause histamine release. Vecuronium is a steroid derivative. The kidney eliminates Gallamine only.
Gentamicin reduces acetylcholine release causing end-plate ion channel blockade. This action potentiates the action of non-depolarizing neuromuscular agents.
(Clearly an interesting medical concept without a clinical application)
Extra: of the non-depolarizing NM blockers, mivacurium causes the most histamine release. Atracurium also causes a slight increase in histamine release.
Which of the following drugs is a direct serotonin agonist?
A Sumatriptan
B Fluoxeteine
C Moclobemide
D Amitryptiline
A
Explanation
Fluoxetein = Selective Serotonine reuptake inhibitor SSRI
Amitryptiline = Tricyclic antidepressant : Blocks reuptake of noradrenaline and serotonin.
Moclobemide = Competitively and reversibly inhibits monoamine oxidase MAO A (selective). Note: from the evidence available, the reversible short acting MAO inhibitor moclobemide, appears to be relatively free of the hypertensive reaction due to tyramine.
Sumatriptan is a selective agonist for 5-HT1D and 5-HT 1B receptors.
Carbamazepine is closely related to which of the following drugs?
A Imipramine
B Quinidine
C Metoprolol
D Sodium valproate
A
Explanation
Carbamazapine resembles (in it’s chemical structure only) tricyclic antidepressants, of which Imipramine is one
Which of the following drugs acts by MAO inhibition?
A Clomipramine
B Paroxetine
C Moclobemide
D Sertraline
C
Explanation
Clomipramine is a tricyclic antidepressent that prevents reuptake of noradrenaline (NA), serotonin.
Paroxetine is a selective serotonin reuptake inhibitor, antidepressant, no effect on NA
Sertraline is a selective serotonin reuptake inhibitor, antidepressant, no effect on NA
Note: Paroxetine and sertraline have no antimuscarinic action (unlike chlomipramine)
Of the following drugs, which is the most dangerous in overdose?
A Paroxeteine
B Imipramine
C Sertraline
D Moclobenide
B
Explanation
Imipramine is a tricyclic antidepressant. In OD it causes VF arrest and coma. A dose of 10mg/kg of a TCA is lethal
A patient on phenytoin is found to have a low blood phenytoin level. Of the following drugs, which is LEAST likely to cause this?
Your answer was correct
A Hypoalbuminemia
B Carbemazepime
C Disulfiram
D Non-compliance
C
Explanation
Disulfiram retards the metabolism of phenytoin. Carbamazapine is an enzyme inducer and will increase phenytoins metabolism. Non-compliance obviously lowers blood levels. Because phenytoin is highly protein bound, low levels of albumin will decrease phenytoin blood levels
Extra: ‘Phenytoin Pharmacokinetics & Drug Interactions’: Low plasma albumin (such as in liver disease or nephrotic syndrome) can result in abnormally high free concentrations and toxicity.’
Extra: (from a subscriber)
Disulfiram only inhibits CYP2C9 Phenytoin is metabolised by CYP2C9 and 2C19. The textbook passage specifically mentions that hypoalbuminemia would cause HIGHER levels of FREE DRUG, but it seems to suggest that patient ‘may show toxicity even at normal/therapeutic drug levels’ - Perhaps the total ‘measured drug level’ is unchanged by hypoalbuminemia - because you are measuring the bound AND unbound part … but the higher amount of ‘free drug’ as a proportion of the whole gives toxicity earlier So hypoalbuminaemia causes a changed fraction of the drug to be bound/unbound but doesn’t affect the overall measured level? (I guess this would also depend on the type of assay)
Regarding SSRIs, which of the following statements is correct?
A They may be associated with seretonin syndrome with muscle weakness, hyperpyrexia and confusion.
B They are safe in overdose due to minimal drug interactions
C They may cause seizures in overdose
D They are readily removed by dialysis
C
Explanation
SSRis are dangerous in OD because they can cause serotonin syndrome that consists of muscle rigidity, hyperpyrexia, and confusion, which can lead to convulsions, coma and rhabdomiolysis. Dialysis is of no benefit as they have high volumes of distrubution